TLRY
Get informed when a big investor buys or sells
+ FollowOvervalued by 150.6% based on the discounted cash flow analysis.
| Market cap | $582.28 Million |
|---|---|
| Enterprise Value | $735.55 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.09 |
| Beta | 1.92 |
| Outstanding Shares | 133,340,533 |
| P/E Ratio | -2.01 |
|---|---|
| PEG | -0.02 |
| Price to Sales | 0.4 |
| Price to Book Ratio | 0.23 |
| Enterprise Value to Revenue | 0.77 |
| Enterprise Value to EBIT | -17.26 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.23 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 74.42% |
|---|---|
| Total Calls | 600▼ 99.99% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.11%▼ 12.27% |
|---|---|
| Total Invested | $462,860▼ 99.26% |
| Investors Holding | 22▼ 234.00% |
No data
Tilray Brands, Inc. operates as a consumer lifestyle company primarily involved in the research, cultivation, manufacturing, and worldwide supply of medical cannabis products. Its expansive global footprint includes Canada, the United St...